Flow Traders U.S.’s Twist Bioscience TWST Stock Holding History

Flow Traders U.S.’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,708	Closed	-$241K	–	988
2020 Q4	$241K	Buy	+1,708	New	+$189K	0.02%	537

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Flow Traders U.S.'s TWST Position: Q1 2021 in Review

Flow Traders U.S. sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 1,708 shares — an estimated $241K sold.

Flow Traders U.S. first reported a position in TWST in Q4 2020 and held it in 1 quarter. The position peaked at $241K in Q4 2020. 239 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

Flow Traders U.S. reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
Flow Traders U.S. sold 1,708 Twist Bioscience shares in Q1 2021, an estimated $241K.
Flow Traders U.S. first reported a position in Twist Bioscience in Q4 2020 and held it in 1 quarter.
Flow Traders U.S.'s Twist Bioscience position peaked at $241K in Q4 2020.
239 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Flow Traders U.S.'s 13F filing for Q1 2021, filed 17 May 2021.